International audienceAcute myeloid leukemia (AML) cells are killed by allogeneic NK cells. However, autologous NK cells from AML patients express decreased levels of activating receptors, and show reduced cytotoxicity. Here, we investigated how interactions between NK and AML cells might cause loss of NK-cell activity in patients. Our results show that AML cell lines and primary blasts alter the NK-cell phenotype, reducing their cytotoxic potential upon prolonged contact. Downregulation of NK-cell-activating receptors was contactdependent and correlated with conjugate formation. Time-lapse imaging of HL60 AML cell line and NK-cell interactions showed a high proportion of noncytolytic contacts. Studies of NK-cell immunological synapses reve...
International audienceNatural Killer (NK) cells are potent anti-leukemic immune effectors. However, ...
International audienceChemotherapies allow complete remission in more than 50 % of patients with acu...
Acute myeloid leukemia (AML) and chronic myelomonocytic leukemia (CMML) are potentially life-threate...
International audienceAcute myeloid leukemia (AML) cells are killed by allogeneic NK cells. However,...
Acute myeloid leukemia (AML) cells induce, in vitro, NK cell abnormalities (NKCAs) including apoptos...
Natural killer (NK) cells are lymphocytes endowed with cytotoxicity against aberrant cells, includin...
International audienceNK cells are defective in acute myeloid leukemia (AML) at diagnosis. Here, we ...
Inflammatory cells of the innate immune system launch rapid and powerful effector responses in the c...
The majority of patients with acute myeloid leukemia will relapse, and older patients often fail to ...
Abstract Immunotherapy has attracted considerable attention as a therapeutic strategy for cancers in...
International audienceNatural killer (NK) cells are major antileukemic immune effectors. Leukemic bl...
Natural killer (NK) cells are circulating CD3− lymphocytes, which express CD56 or CD16 and an array ...
International audienceNatural Killer (NK) cells are potent anti-leukemic immune effectors. However, ...
International audienceChemotherapies allow complete remission in more than 50 % of patients with acu...
Acute myeloid leukemia (AML) and chronic myelomonocytic leukemia (CMML) are potentially life-threate...
International audienceAcute myeloid leukemia (AML) cells are killed by allogeneic NK cells. However,...
Acute myeloid leukemia (AML) cells induce, in vitro, NK cell abnormalities (NKCAs) including apoptos...
Natural killer (NK) cells are lymphocytes endowed with cytotoxicity against aberrant cells, includin...
International audienceNK cells are defective in acute myeloid leukemia (AML) at diagnosis. Here, we ...
Inflammatory cells of the innate immune system launch rapid and powerful effector responses in the c...
The majority of patients with acute myeloid leukemia will relapse, and older patients often fail to ...
Abstract Immunotherapy has attracted considerable attention as a therapeutic strategy for cancers in...
International audienceNatural killer (NK) cells are major antileukemic immune effectors. Leukemic bl...
Natural killer (NK) cells are circulating CD3− lymphocytes, which express CD56 or CD16 and an array ...
International audienceNatural Killer (NK) cells are potent anti-leukemic immune effectors. However, ...
International audienceChemotherapies allow complete remission in more than 50 % of patients with acu...
Acute myeloid leukemia (AML) and chronic myelomonocytic leukemia (CMML) are potentially life-threate...